Kospi more than doubled from pandemic nadir a year ago
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
The Kospi closed at 3,054.39 last Friday, up 109.54 percent from a year earlier when the Covid-19 was declared a pandemic by the World Health Organization. The junior Kosdaq index made even sharper recovery over a year, making 116.06 percent gain. On Tuesday, Kospi finished 0.7 percent higher at 3,067.17 and Kosdaq up 1.48 percent at 940.65.
Both Korean stock markets have far outpaced its global peers. In the U.S., S&P 500 rose 76.25 percent and Nasdaq 94.15 percent over the same period. Nikkei 225 in Japan gained 79.53 percent, and DAX 30 in Germany 71.79 percent. China, which escaped from the pandemic faster than other countries, has seen Shanghai Composite Index rise by 29.81 percent. The growth was also slow in the U.K with FTSE 100 Index gaining 35.39 percent. Hong Kong’s Hang Seng has increased 35.95 percent.
Korea Exchange’s data show that retail investors net purchased 62.2 trillion won ($54.9 billion) in the Kospi over the last one-year period, while institutions net sold 42.9 trillion won and foreigners 19.05 trillion won over the same period.
But market analysts warn of corrections in Korean stocks after the fast recovery amid increasing volatility from the rising U.S. bond yields.
“It is important to witness whether corporate earnings improve in line with the economic recovery,” said Yang Hye-jung, an analyst at DS Investment & Securities. “If the corporate performance is on a recovery track, the market should certainly endure volatility,” Yang added.
Korea is considered to be one of few countries that have weathered the negative economic impact from the Covid-19 crisis relatively well compared to other major economies in the world. Corporate investments continued across sectors ranging from electric vehicle battery and biotech to mobile game and internet.
Of the big winners in the Korean market, shares of Shinpoong Pharmaceutical surged 1,284 percent over a year after the company came under spotlight for the possibility of its antimalarial drug used to treat Covid-19 patients.
Doosan Fuel Cell also skyrocketed 1,094 percent, container carrier HMM 829 percent, Sambu Construction 772 percent, entertainment contents provider YG Plus 728 percent and SC Engineering 711 percent.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- S. Korea’s credit card spending down for the first time in 16 yrs - Pulse by Maeil Business News Korea
- S. Korea’s unemployment allowance reaches 5-month high on sluggish service sector - Pulse by Maeil Business News Korea
- Korean state lab successfully localizes key hydrogen fuel cell material PFSA - Pulse by Maeil Business News Korea
- Google to lower in-app commission rate by half for developers - Pulse by Maeil Business News Korea
- Kospi more than doubled from pandemic nadir a year ago - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 타깃 마케팅 광고 독보적…100억명에 노출 [천억클럽]
- 은퇴 암시했던 보아, 팬들과 소통 재개… ‘데뷔 24주년 점핑이들과 함께’ - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이